OMNIGEN BIODATA LTD
Significant control: Manjinder Singh Sandhu (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Omnigen Biodata Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Omnigen Biodata Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
OMNIGEN BIODATA LTD is an active private limited company (company number 10565653) incorporated on 16 January 2017, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £6.67m and cash of £638k, with 16 employees on average. Net assets rose 51% on the prior period (£4.41m).
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Dr Manjinder Singh Sandhu
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Deepti Gurdasani
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 January 20179 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 30 January 2027in 97 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £6.67m | £638k | £2.11m | — | — | — | 16 |
| 31 December 2024 | £4.41m | £550k | £1.15m | — | — | — | 25 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £6,674,514 at 31 December 2025
- Net assets up 10% or more on the prior period+51.2% vs prior period
- Cash at bank of £50,000 or moreCash £638,309
- Incorporated five or more years agoIncorporated 16 January 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 97 days
- Accounts period endNet assets £6.67m · small accounts
- Accounts period endNet assets £4.41m · small accounts
- Incorporated
Similar companies in Cambridge
- SCI BIO LIFE SCIENCES CONSULTANCY LIMITEDCambridge · inc. Jan 2017
- RXBIOLOGICS LIMITEDCambridge · inc. Jan 2017
- PLAYPHYSIO C.I.C.Cambridge · inc. Jan 2017
- NORTHSTAR BIOLOGY LTDCambridge · inc. Mar 2017
- ELECTRONRX LIMITEDCambridge · inc. Mar 2017
- QKINE LIMITEDCambridge · inc. Nov 2016
All companies incorporated on 16 January 2017 · in Jan 2017.
Reminders for OMNIGEN BIODATA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.